Use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium

Details for Australian Patent Application No. 2007209331 (hide)

Owner Centre National De La Recherche Scientifique (CNRS)

Inventors Rousselot, Morgane; Zal, Franck

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007209331

PCT Pub. Number WO2007/085596

Priority 60/761,358 24.01.06 US

Filing date 23 January 2007

Wipo publication date 2 August 2007

Acceptance publication date 11 October 2012

International Classifications

C07K 14/00 Peptides having more than 20 amino acids

Event Publications

21 August 2008 PCT application entered the National Phase

  PCT publication WO2007/085596 Priority application(s): WO2007/085596

11 October 2012 Application Accepted

  Published as AU-B-2007209331

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007209333-Curable composition

2007209317-System for the construction of a semiprefabricated building